Home > Insider Trading > Ptc Therapeutics Inc.

Ptc Therapeutics Inc. (PTCT)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the PTC Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. All participants are in listen only mode.

Keep Reading →

February 28th, 2025 - News Transcripts

Why PTC Therapeutics (PTCT) Stock Is Rallying Today

The bank believes that, in the wake of the results from the Phase 3 trial of PTCT's drug known as Sepiapterin, the product is viewed as likely to be approved by the FDA.

Keep Reading →

February 3rd, 2025 - Market Movers News

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2024 Earnings Call Transcript

Operator: Welcome to the PTC Third Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Keep Reading →

November 9th, 2024 - News Transcripts

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2024 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to PTC Second Quarter 2024 Financial Results Conference Call.

Keep Reading →

August 10th, 2024 - News Transcripts

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript

PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.

Keep Reading →

April 30th, 2024 - News Transcripts

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript

PTC Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $0.29.

Keep Reading →

March 2nd, 2024 - News Transcripts

Analysts on Wall Street Lower Ratings for These 5 Stocks

On December 19, Morgan Stanley analyst Jeffrey Hung downgraded PTC Therapeutics, Inc. (NASDAQ:PTCT) from Equalweight to Underweight, within the biotechnology industry.

Keep Reading →

December 20th, 2023 - News

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the PTC Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

October 30th, 2023 - News Transcripts

PTC Therapeutics (PTCT) Lost 16% in Q2

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here.

Keep Reading →

September 25th, 2023 - Hedge Fund Investor Letters News

Analysts on Wall Street Lower Ratings for These 5 Stocks

Federal Realty Investment Trust (NYSE:FRT) is a leading real estate company specializing in high-quality retail properties in major coastal markets from Washington, D.C., to Boston, San Francisco, and...

Keep Reading →

September 19th, 2023 - Market Movers News